The choice of biomaterials available for regenerative medicine continues to grow rapidly,
with new materials often claiming advantages over the short-comings of those already in …

Background Acute spinal cord injury (ASCI) is a catastrophic event that can profoundly affect
the trajectory of a patient's life. Debate continues over the pharmacologic management of …

Attractive physic-chemical features of graphene oxide (GO) and promising results in vitro
with neural cells encourage its exploration for biomedical applications including neural …

Nerve regeneration and functional recovery have been a major issue following injury of
nerve tissues. Electrospun nanofibers are known to be suitable scaffolds for neural tissue …

Spinal cord injury (SCI) leads to disruption of the blood–spinal cord barrier, hemorrhage,
and tissue edema, which impair blood circulation and induce ischemia. Angiogenesis after …

The control and manipulation of cells that trigger secondary mechanisms following spinal
cord injury (SCI) is one of the first opportunities to minimize its highly detrimental outcomes …

Diseased or injured nervous systems lead to lifelong disability and even death due to their
limited self-repair and regenerative capability. For successful neuronal regeneration and …

Spinal cord injury (SCI) is a major disability requiring more effective treatment than is
currently available. Micro RNA s have been shown to effectively regulate gene expression at …

The heterogeneity of the primary mechanical mechanism of spinal cord injury (SCI) is not
currently used to tailor treatment strategies because the effects of these distinct patterns of …

The use of carbon nanotubes (CNTs) to promote neural differentiation is well known.
However, most studies have focused on the effect of CNT-derived composites or CNT-based …